Case Report

TSH Isoforms: About a Case of Hypothyroidism in a Down's Syndrome Young Adult

Table 1

Control of initial thyroid parameters TSH, FT3, and FT4 by different assays and additional biological parameters.

Patient’s resultsReference values

TSH139210.25–4 mIU/L
120020.27–4.2 mIU/L
15403*0.29–3.8 mIU/L

FT40.6648.2–18 pmol/L
1.6511.5–23 pmol/L
1.35*13–22.6 pmol/L

FT31.1444.2–8.3 pmol/L
1.752.5–5.8 pmol/L
1.95*2.8–5.3 pmol/L

Anti-thyroid peroxidase antibodies (AbTPO) 64047<60 kU/L

Thyroglobulin (Tg) 1< 0.7<50 μg/L

Anti-thyroglobulin antibodies (AbTg) 6198<60 kU/L

Anti-TSH receptor antibodies (TSHR) 6216<1.0 U/L

Blocking anti-TSHR 7 81<10%

Stimulating anti-TSHR 7243 100%

Anti-T3 antibodies 74.9<7.9%

Anti-T4 antibodies 73.7<7%

Anti-TSH antibodies 713<18%

Total cholesterol89.34.5–6.0 mmol/L

Total Testosterone111.38.2–34.6 nmol/L

Alpha-subunits32.8<0.8 IU/L
Prolactin3100930–545 mIU/L

Luteinizing hormone (LH) 34.61.8–8.4 IU/L

Follicle-stimulating hormone (FSH) 318.32.2–10 IU/L

Radioelectrophoresis:
 (i) Thyroxin-Binding Protein69.763.6–81.2%
 (ii) Albumin6.02.9–9.7%
 (iii) Transthyretin23.812.5–29.7%
 (iv) Immunoglobulins0.5<2.0%

1CisBio, 2Modular Roche Diagnostic, 3 IRMA Beckman Coulter, 4RIA lisophase Cis Bio, 5RIA Beckman Coulter, 6Brahms, 7in-house assay, Biological Center Lyon Sud, 8 Olympus. *Pretreatment with “Heterophilic Blocking Tube’’ scantibodies.